Showing results (811-820 of 1,678) with videos related to
Sort By:
Pageof 168
Bioorganic & Medicinal Chemistry|March 14, 2016
Development of a potent 2-oxoamide inhibitor of secreted phospholipase A2 guided by molecular docking calculations and molecular dynamics simulationsSofia Vasilakaki, Efrosini Barbayianni, Georgios Leonis, et al.Anesthesiology|September 1, 1992
The responsiveness of cerebral blood flow to changes in arterial carbon dioxide is maintained during propofol-nitrous oxide anesthesia in humansJ Fox, A W Gelb, J Enns, et al.The Journal of Clinical Endocrinology and Metabolism|April 9, 2004
Decreased bone turnover and deterioration of bone structure in two cases of pycnodysostosisNadja Fratzl-Zelman, Angelika Valenta, Paul Roschger, et al.Chest|December 15, 2004
Simplified detection of dynamic hyperinflationArthur F Gelb, Carlos A Gutierrez, Idelle M Weisman, et al.Journal of General Internal Medicine|January 21, 2006
Measuring patients' experiences with individual primary care physicians. Results of a statewide demonstration projectDana Gelb Safran, Melinda Karp, Kathryn Coltin, et al.The Journal of Biological Chemistry|June 3, 1994
Tight binding inhibitors of 85-kDa phospholipase A2 but not 14-kDa phospholipase A2 inhibit release of free arachidonate in thrombin-stimulated human plateletsF Bartoli, H K Lin, F Ghomashchi, et al.Human Pathology|November 1, 1993
Infantile histiocytoid cardiomyopathy--myocardial or conduction system hamartoma: what is the cell type involved?A B Gelb, S H Van Meter, M E Billingham, et al.Canadian Journal of Anaesthesia = Journal Canadien D'Anesthesie|February 16, 2000
Rate of change of cerebral blood flow velocity with hyperventilation during anesthesia in humansK Y Chong, R A Craen, J M Murkin, et al.The Journal of Investigative Dermatology|February 13, 2001
Characterization of group X phospholipase A(2) as the major enzyme secreted by human keratinocytes and its regulation by the phorbol ester TPAA Schadow, K Scholz-Pedretti, G Lambeau, et al.Biochimica Et Biophysica Acta|July 27, 2001
A pyrrolidine-based specific inhibitor of cytosolic phospholipase A(2)alpha blocks arachidonic acid release in a variety of mammalian cellsF Ghomashchi, A Stewart, Y Hefner, et al.Pageof 168